Coumarin analogue 3-methyl-7H-furo[3,2-g]chromen-7-one as a possible antiparkinsonian agent

INTRODUCTION: Parkinson’s disease is the second most common neurodegenerative disease. Monoamine oxidase B inhibitors are used in the treatment of this disease concomitantly with levodopa or as monotherapy. Several substituted coumarins have shown activity as inhibitors of monoamine oxidase B. OBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales: Olaya, María del Pilar, Vergel, Nadezdha Esperanza, López, José Luis, Viña, María Dolores, Guerrero, Mario Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2019
Materias:
Articulo Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357371/
https://www.ncbi.nlm.nih.gov/pubmed/31584763
http://dx.doi.org/10.7705/biomedica.4299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357371/
https://www.ncbi.nlm.nih.gov/pubmed/31584763
http://dx.doi.org/10.7705/biomedica.4299

Ejemplares similares